Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.
Lubna Naaz ChaudharyJulie M JornsYunguang SunYee Chung ChengSailaja KamarajuJohn BurfeindMary Beth GonyoAmanda L KongCaitlin PattenTina YenChandler S CortinaEbony CarsonNedra JohnsonCarmen BergomShirng-Wern TsaihAnjishnu BanerjeeYu WangInna ChervonevaElizabeth WeilChristopher R ChitambarHallgeir RuiPublished in: Breast cancer research and treatment (2023)
Trial registration number: NCT03219476.